Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

NCT04360317 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: Combination of SH003 and Docetaxel

Sponsor

Kyunghee University Medical Center